Background: Platelet derived growth factors (PDGFs) (Folia Morphol 2017; 76, 4: 551-557) 
INTRODUCTION
Platelet derived growth factors (PDGFs) are synthesized and secreted by a variety of cells, including fibroblasts, muscle cells, and glial cells [13, 17, 23] . PDGFs combine with tyrosine kinase receptors (platelet-derived growth factor receptors, PDGFRs), have been extensively studied in developing organisms [3, 5, 10] , and play key roles in the process of development [1] , promotion of cell mitosis, and chemotaxis, but can also induce series of biological effects, such as cell proliferation, differentiation, and the prevention of apoptosis [1, 7] .
Yet the physiological roles of PDGFs in adult animals remain poorly understood [1, 4] . All PDGFs function as secreted, disulphide-linked homodimers, but only PDGF-alpha and PDGF-beta (PDGFA and PDGFB) can form functional heterodimers, and have been widely studied. The structure and function of the PDGFA protein are similar to those of vascular endothelial growth factor (VEGF) proteins [2, 8] , which are also highly conserved in evolution [19] , and contain a cysteine knot motif in common with PDGFs [15] . PDGFRA signalling is not required for the specification of oligodendrocyte progenitors (OPs), but the further proliferation and spreading of OPs in the central nervous system (CNS) depend on PDGFA signalling through PDGFRA [16] . PDGFA drives not only the proliferation of OPs in the embryo, but it also determines the number of OPs in the adult brain [26] . PDGFA is also a critical ligand for PDGFRA in oligodendrocyte development. PDGFA is expressed by neurons and astrocytes throughout the CNS, and is constitutively released from neural cell bodies. Moreover, it is also closely related to pathologies associated with the stress of hypoxic conditions [12, 13] . Domestic yaks (Bos grunniens) on the Qinghai Tibet Plateau are less sensitive to and readily adapt to hypoxia [11, 27] . Undoubtedly the yak brain plays an important role in this high-altitude hypoxia adaptation. Many researchers have previously investigated the characteristics of PDGFA in other animals, and its expression in brain tissue, under hypoxic stress for short periods of time. These studies have often observed the transition to "normal" oxygen levels (i.e. O 2 : 21%) after birth. However, yak PDGFAs have not been characterised, despite the yak having lived in hypoxic environments for most of its evolutionary history, yet alone each animal's lifetime. Therefore, our study of the characteristics and expression of yak PDGFA in brain tissue should prove highly informative.
In our study, the characteristics of yak PDGFA were analysed, and its expression in yak brain tissues was studied by quantitative real-time polymerase chain reaction (qRT-PCR), western blot, and immunohistochemistry. Our study should prove helpful for exploring the effects of PDGFA in hypoxia regulatory processes related to physiological function in this Tibet Plateau species.
MATERIALS AND METHODS

Yak brain sampling
The brain tissues (cerebrum, cerebellum, hippocampus, and spinal cord) and skin tissue of yak (n = 5, 3 years old) were obtained from the Lejiawan slaughterhouse, located in Xining City, Qinghai Province, China. All experimental and surgical procedures were approved by the Biological Studies Animal Care and Use Committee, Qinghai Province, People's Republic of China. Brain tissue samples were fixed using 4% neutral paraformaldehyde for immunohistochemical staining; other brain samples and skin samples were quick frozen in liquid nitrogen for protein and RNA extraction.
Primer design and PCR amplification
Bos grunniens glyceraldehyde-3-phosphate dehydrogenase (GAPDH, GenBank: EU195062) was used as a reference control. PDGFA sequences of cattle (Bos taurus, GenBank: NM001075231) and Asian buffalo (Bubalus bubalus, GenBank: JQ326282) served as references for coding region PCR primer design. Those PDGFA coding regions were aligned with the yak genome sequence (NCBI genome assembly: BosGru_v2.0), and conserved upstream and downstream sequences were selected for qRT-PCR primer design with Primer Premier 6.0 (Applied Biosystems) ( Table 1) . Evolutionary inference and sequence similarity analysis were performed with MEGA 6.0 and DNA Star. RNA was extracted from collected skin tissues using an RNA Total Kit (Tiangen Bio, Beijing, China). First strand cDNA synthesis was performed using a reverse transcription kit (TaKaRa Bio, Dalian, China) according to the manufacturer protocol, with oligo-dT primers and approximately 1 μg of total RNA as a template. PCR was carried out in a 20 μL reaction system containing 1 μL cDNA template, 10 μL Taq DNA polymerase Master Mix (Promega, USA), 1 μL each forward and reverse primer (0.2 μmol/mL), and ddH2O (up to 20 μL). PCR conditions were as follows: initial denaturation for 5 min at 95°C, 35 cycles at 94°C for 30 s, annealing temperature of 60°C for 10 s, and extension at 72°C for 30 s. The final extension step was followed by a 10 min extension at 72°C. The PCR products were separated in 1.2% agarose gel, and then sent for Sanger dideoxy sequencing (The Beijing Genomics Institute, Beijing, China).
Real-time PCR analysis
Quantitative real-time PCR reactions were performed on an Applied Biosystems ViiA™ 7 Real-Time PCR System (Thermo Fisher Scientific Inc., Waltham, MA, USA), with equal amounts of 10 μL SYBR Green II Master Mix, 0.4 μL Passive Reference Dye II (Takara, Dalian, China), 1.0 μL each forward and reverse primers (10 μmol/L), 6.6 μL ddH2O, and 1 μL cDNA in a final volume of 20 μL. Standard amplification conditions were 3 min at 95°C, and 42 cycles of 10 s at 95°C, followed by 32 s at 60°C. Afterwards, the corresponding dissociation curves were analysed. Each qRT-PCR run included GAPDH control and target genes, and each sample was repeated 3 times. We analysed the relative expression of mRNA of each gene by quantitative fluorescence, with the level of GAPDH expression being used as an endogenous control, and using the 2 -rr Ct method to analyse relative gene expression [21] .
Western blot analysis for PDGFA
Total protein extracted from the brain tissues was obtained using a protein extraction kit (Beyotime Biotechnology, Jiangsu, China) according to the manufacturer's instructions. Protein concentrations were measured by the bovine serum albumin (BSA) method (Pierce, Rockford, IL, USA) using BSA as the standard. The protein samples were diluted to the same concentration. Mixtures of equal amounts (20 μg) of protein from each sample in loading buffer were denatured at 100°C for 5 min and separated by SDS-PAGE before transfer of the semi-dry samples onto polyvinyl difluoride (PVDF) membranes. Western immunoblotting was carried out with anti-PDGFA (Bisso, bs-10073R, Beijing, China) primary antibodies at a 1:250 dilution, and samples were incubated for 2 h at 37°C. After washing 3 times with Dulbecco's phosphate buffered saline (DPBS), the appropriate horseradish peroxidase-conjugated secondary antibody (Bisso, bs-0295D, Beijing, China) was incubated with the blot for 1 h at 37°C, followed by washing 3 times in DPBS. The bands were visualised with a chemiluminescence detection kit (ECL, Rockford, IL, USA), and the result was analysed by ImageJ Software v. . The relative intensity of the target protein is proportional to the target band grey value/beta-actin band gradation value. Beta-actin was used as a loading control.
Immunofluorescence analysis for PDGFA
The skin brain tissue sections were incubated at room temperature in 3% H 2 O 2 for 10 min to block the action of any endogenous peroxidase. The immunofluorescence analysis for PDGFA was performed according to the manufacturer's instructions. Afterward, sections were incubated at 4°C overnight in the primary antibody solution with anti-anti-PDGFA (Bisso, bs-10073R, Beijing, China) (1:50). Following three 5-min washes in 0.1 mol/L phosphate buffered saline (PBS), sections were incubated with the secondary antibody, HRP-anti-rabbit IgG (Bisso, bs-0295D, Beijing, China, 1:100) for 30 min at 37°C. After washing with 0.1 mol/L PBS three additional times, DAB (3,3'-diaminobenzidine) staining was applied, using BSA instead of the primary antibody as a negative control in the reaction. Immunofluorescence was then observed under a fluorescence microscope at 400× magnification (Olympus-71, Japan).
Statistical analysis
Data were expressed as the mean ± standard error of the mean (SEM). Statistical analyses were performed using one-way ANOVA. All statistical computations were performed using SPSS software (version 13.0). The significance level was set at p < 0.05. Protein abundance (n = 3 replicates) was determined by analysis of variance. Each experiment was repeated at least three times.
RESULTS
Characteristic of yak PDGFA gene
The yak PDGFA cDNA sequence we obtained comprises 755 bp containing an open reading frame (ORF) of 636 bp, starting with an ATG start codon at position 2, and ending with a TAA stop codon at position 637, encoding 211 amino acid residues (Fig. 1) . Our yak PDGFA cDNA sequence has been deposited in GenBank with accession no. KU851801.
Pairwise DNA sequence identities between yak and mouse, human, dog, pig, and sheep, PDGFA gene sequences are 83.8%, 86.2%, 86.8%, 91.3%, and 93.8%, respectively. Sequence identities between the yak and Asian buffalo, and against the cattle gene sequence are much higher, both 98.1% (Fig. 2) . This highly conserved pattern of PDGFA evolution is displayed in Figure 3 
Relative expressions of yak PDGFA gene
We measured the expression level of PDGFA mRNA in the cerebrum, cerebellum, hippocampus, and spinal cord by qRT-PCR (Fig. 5) . The expression of PDGFA mRNA was the highest in the cerebrum and the lowest in the hippocampus; there was no significant difference between the hippocampus and spinal cord (p > 0.05) (Fig. 5) . Relative PDGFA mRNA expression levels in the cerebrum and cerebellum were significantly higher than in hippocampus tissue (p < 0.05) (Fig. 5) .
Yak PDGFA expression in protein level
There was considerably more PDGFA protein in the cerebrum and cerebellum than in the hippocampus and spinal cord (Fig. 6A) . The lowest level of PDGFA protein expression was in the hippocampus and spinal cord, with no significant difference between the two (p > 0.05). PDGFA protein levels in the cerebrum and cerebellum tissues were significantly higher than in hippocampus tissue (p < 0.05) (Fig. 6B) .
Immunofluorescence staining of PDGFA
PDGFA was primarily located in the nucleus of glial cells and pyramidal cells of yak cerebrum (Fig. 7A) , in the cytoplasm of cerebellum Purkinje cells, and in glial and stromal cells of the cerebellum (Fig. 7B) . A small amount was located in glial cells of the hippocampus (Fig. 7C) . Negative results were obtained in yak spinal cord (Fig. 7D) . 
DISCUSSION
We successfully amplified a 755 bp yak PDGFA gene fragment that includes a 636 bp ORF, encoding 211 amino acids (GenBank: KU851801). A multiple sequence alignment between the yak PDGFA nucleotide and amino acid sequence with the cattle and Asian buffalo sequences shows 8 SNP sites (Fig. 4A) , resulting in 4 amino acid substitutions (Fig. 4B) . These variations may have important biological significance, perhaps conferring PDGFA functional physiological advantages under hypoxic conditions. The expression of PDGFA in other animals has been shown to relate to environmental stress, including hypoxia [23] ; therefore, the unique characteristics of yak PDGFA could be a crucial factor in high altitude hypoxia adaption.
PDGFs, as key autocrine and paracrine growth factors, play important roles in embryonic development, particularly those that promote the development of the CNS and related organs [9] . PDGFA contributes to CNS oligodendrocyte growth and nuclear proliferation under standard physiological conditions [1, 26] . Our results show that yak brain cerebrum, cerebellum, hippocampus, and spinal cord tissues all express the PDGFA gene and its protein at varying levels, and are widely expressed throughout various parts of the adult yak CNS under normal physiological conditions. The roles of PDGFs in adult animals' nervous systems should not be ignored. Whether the differences in PDGFA gene and protein expression levels between different tissues of the brain relate to yak's long-term physiological adaptabilities in hypoxic environments remains a question. Further study requires a more detailed examination of yak PDGFA gene specificity.
Our immunohistochemistry results show the PDGFA protein to be highly expressed in yak cerebrum tissue glial cells and pyramidal cells, and especially so in Purkinje cells, as well as in cerebellum and hippocampus tissues, but considerably less in spinal cord tissues, under normal physiological conditions. This is consistent with previous studies [22, 25] . The PDGFA protein mainly occurs in CNS glial cells and neurons. We confirmed the distribution of PDGFA in the cerebrum tissue of yak pyramidal cells and Purkinje cells. This particular expression pattern has not been reported in other species. PDGFA protein in the spinal cord could be detected by western blot, but not by immunohistochemistry, which may be due to its similarity to VEGF proteins [8, 24] . Our present study only focused on nerve cells, and PDGFA may also be expressed in vascular endothelial cells. Our team is currently working on this subsequent analysis in yak.
Other members of the PDGFs family exist in addition to PDGFA, including PDGFB [8, 14] . These growth factors and the associated receptors, not only play important biological roles in embryonic development and organ formation [13] , but also affect the physiology of adult animals, including neuroprotective and anti-tumour effects [1, 20] . However, the molecular mechanism and transcriptional regulation of various PDGF family members vary [6, 14] . Therefore, whether other PDGF family members participate in the regulation of yak physiological function should be further explored.
CONCLUSIONS
Our study shows the PDGFA gene to be highly evolutionarily conserved, with high sequence identities within mammals. Nonetheless, the yak PDGFA gene and its protein have several species-specific characteristics. The yak PDGFA gene and its protein are widely expressed in the yak brain. However, differences in yak PDGFA expression levels in the cerebrum, cerebellum, hippocampus, and spinal cord suggest that PDGFA may affect adaptive physiological functions in the yak, and require further study.
